Clinical Trial Update: A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer [Phase 3]

View source ↗

Summary

A Phase III trial evaluating PROCRIT (epoetin alfa) versus placebo in women undergoing adjuvant chemotherapy for breast cancer was terminated. The study also ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Ortho Biotech Products, L.P. | Conditions: Anemia, Breast Neoplasms | Phase 3 | Status: TERMINATED